EyePoint Pharmaceuticals (EYPT) stock forecast for 2022 – 2027

Are you interested in EyePoint Pharmaceuticals, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the EYPT stock price in 2022-2027. Is EYPT a good long term stock? When should I take profit in EyePoint Pharmaceuticals stock? Buy or sell stock? Will EYPT stock price go up? What are analysts’ forecasts for EYPT stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. EYPT stock returns are also predicted based on historical data.

According to our research, EYPT stock is a very good long-term investment. EYPT share price has been in a bull cycle for the past year. EyePoint Pharmaceuticals, Inc. stock trend is positive.

EyePoint Pharmaceuticals company info

Industry Biotechnology
Address 480 Pleasant Street, Watertown, MA, 02472, United States
Website https://eyepointpharma.com

Forecasting

52 Week High: 12.5314 USD
52 Week Low: 8.97582 USD
1 Year Forecast: 12.7846 USD
5 Year Forecast: 26.0464 USD

Agilent Technologies info

Market Cap: 321.99M
52 Week Change: -3.227%
52 Week High: 21.5 USD
52 Week Low: 7.3 USD
Beta: 1.55718
50 Day Moving Average: 11.87
90 Day Moving Average: 13.328
200 Day Moving Average: 11.63
Resistance Level: 10.2847
Pivot Point: 9.29907
Support Level: 8.493
Enterprise Value: 307,983,072
Forward P/E: -4.00
Forward EPS: -2.17
Profit Margin: -167.42%
Shares Outstanding: 33,899,400
EBITDA: -6.61
Held Percent Institutions: 68.07%
PEG Ratio (5Y): 0
Trailing EPS: -2.25

EyePoint Pharmaceuticals stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

EyePoint Pharmaceuticals Stock Forecast for 2022

March 2022 9.09 8.82 -2.97%
April 2022 8.82 8.82 0%
May 2022 8.91 10.2 14.48%
June 2022 10.2 10 -1.96%
July 2022 10 10 0%
August 2022 10 9.8 -2%
September 2022 9.9 11.11 12.22%
October 2022 11 11.22 2%
November 2022 10.78 11.11 3.06%
December 2022 11.22 12.12 8.02%

EyePoint Pharmaceuticals Stock Forecast for 2023

January 2023 11.76 12.12 3.06%
February 2023 12 11.76 -2%
March 2023 11.76 12.24 4.08%
April 2023 12.24 13 6.21%
May 2023 12.87 13 1.01%
June 2023 13.26 12.74 -3.92%
July 2023 12.87 14.14 9.87%
August 2023 14.28 14.28 0%
September 2023 14 14.28 2%
October 2023 13.72 15 9.33%
November 2023 14.85 15.3 3.03%
December 2023 14.7 14.85 1.02%

EyePoint Pharmaceuticals Stock Forecast for 2024

January 2024 14.7 15.68 6.67%
February 2024 16.32 16.16 -0.98%
March 2024 16 16 0%
April 2024 16 15.68 -2%
May 2024 15.68 17.34 10.59%
June 2024 17.17 17.17 0%
July 2024 17 17.34 2%
August 2024 16.66 16.83 1.02%
September 2024 18 18.36 2%
October 2024 18.36 17.82 -2.94%
November 2024 18.36 17.82 -2.94%
December 2024 18.18 19 4.51%

EyePoint Pharmaceuticals Stock Forecast for 2025

January 2025 18.81 18.62 -1.01%
February 2025 18.62 19.38 4.08%
March 2025 19.38 19 -1.96%
April 2025 19.19 19.6 2.14%
May 2025 19.8 19.8 0%
June 2025 20.2 19.8 -1.98%
July 2025 19.8 21 6.06%
August 2025 21 20.79 -1%
September 2025 21.21 21.21 0%
October 2025 21.21 22 3.72%
November 2025 22.22 21.56 -2.97%
December 2025 22.22 22 -0.99%

EyePoint Pharmaceuticals Stock Forecast for 2026

January 2026 22.44 23.46 4.55%
February 2026 23.46 23 -1.96%
March 2026 23 23 0%
April 2026 23 23.46 2%
May 2026 22.54 24 6.48%
June 2026 23.76 24.48 3.03%
July 2026 23.76 23.76 0%
August 2026 24.48 24.24 -0.98%
September 2026 24.24 25.5 5.2%
October 2026 25.25 25 -0.99%
November 2026 24.75 25 1.01%
December 2026 24.5 26.26 7.18%

EyePoint Pharmaceuticals Stock Forecast for 2027

January 2027 25.48 25.48 0%